Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Strengthening the Family - the 'Five-I' Approach.

Kalra S, Saboo B, Cho NH, Sadikot S, Hasnani D, Chandarana H, Verma M, Bhandari S, Gupta A, Aravind SR.

Eur Endocrinol. 2019 Apr;15(1):15-16. doi: 10.17925/EE.2019.15.1.15. Epub 2019 Apr 12.

2.

Immunostimulatory plant polysaccharides impede cancer progression and metastasis by avoiding off-target effects.

Varghese S, Joseph MM, Aravind SR, Unnikrishnan BS, Pillai KR, Sreelekha TT.

Int Immunopharmacol. 2019 Aug;73:280-292. doi: 10.1016/j.intimp.2019.05.025. Epub 2019 May 21.

PMID:
31125927
3.

Recommendations for in-clinic PoCT for diabetes management in India.

Saboo B, Sadikot S, Prasanna Kumar KM, Joshi S, Aravind SR, Makkar BM, Chawla R, Kesavadev J, Chawla M, Kovil R, Shah T, Mohit M, Vyas C, Dhandhania VK.

Diabetes Metab Syndr. 2019 Jan - Feb;13(1):5-7. doi: 10.1016/j.dsx.2018.05.005. Epub 2018 May 8.

PMID:
30641753
4.

Cross-sectional survey of biosimilar insulin utilization in Asia: The Joint Asia Diabetes Evaluation Program.

Gani L, Lau E, Luk A, Sobrepena L, Tran QK, Kesavadev J, Jia W, Yu W, Tsang CC, Mukhopadhyay M, Jha S, Sheu W, Ho YK, Nguyen TK, Ozaki R, So WY, Kwan C, Fu AWC, Mirasol R, Phatak SR, Kumar KMP, Aravind S, Janakiraman H, Chan JCN; JADE Collaborative Study Group.

J Diabetes Investig. 2018 Nov;9(6):1312-1322. doi: 10.1111/jdi.12843. Epub 2018 Apr 24.

5.

Validation of Malayalam Version of National Comprehensive Cancer Network Distress Thermometer and its Feasibility in Oncology Patients.

Biji MS, Dessai S, Sindhu N, Aravind S, Satheesan B.

Indian J Palliat Care. 2018 Jan-Mar;24(1):67-71. doi: 10.4103/IJPC.IJPC_160_17.

6.

Influence of cytokine status on insulin resistance and circulating endothelial progenitor cells in type 2 diabetes mellitus.

Sosale B, Chandrashekara S, Aravind SR, Renuka P, Anupama KR.

Cytokine. 2017 Nov;99:179-185. doi: 10.1016/j.cyto.2017.09.012. Epub 2017 Sep 23.

PMID:
28950189
7.

The role of p53-microRNA 200-Moesin axis in invasion and drug resistance of breast cancer cells.

Alam F, Mezhal F, El Hasasna H, Nair VA, Aravind SR, Saber Ayad M, El-Serafi A, Abdel-Rahman WM.

Tumour Biol. 2017 Sep;39(9):1010428317714634. doi: 10.1177/1010428317714634.

PMID:
28933253
8.

High Grade Serous Cystadenocarcinoma of Testis-Case Report of a Rare Ovarian Epithelial Type Tumour.

Aravind S, Nayanar SK, Varadharajaperumal R, Satheeshbabu TV, Balasubramanian S.

J Clin Diagn Res. 2017 Jun;11(6):ED13-ED15. doi: 10.7860/JCDR/2017/27743.10097. Epub 2017 Jun 1.

9.

The INtegrating DEPrEssioN and Diabetes treatmENT (INDEPENDENT) study: Design and methods to address mental healthcare gaps in India.

Kowalski AJ, Poongothai S, Chwastiak L, Hutcheson M, Tandon N, Khadgawat R, Sridhar GR, Aravind SR, Sosale B, Anjana RM, Rao D, Sagar R, Mehta N, Narayan KMV, Unutzer J, Katon W, Mohan V, Ali MK.

Contemp Clin Trials. 2017 Sep;60:113-124. doi: 10.1016/j.cct.2017.06.013. Epub 2017 Jun 19.

10.

Low-Flow Extracorporeal Carbon Dioxide Removal Using the Hemolung Respiratory Dialysis System® to Facilitate Lung-Protective Mechanical Ventilation in Acute Respiratory Distress Syndrome.

Akkanti B, Rajagopal K, Patel KP, Aravind S, Nunez-Centanu E, Hussain R, Shabari FR, Hofstetter WL, Vaporciyan AA, Banjac IS, Kar B, Gregoric ID, Loyalka P.

J Extra Corpor Technol. 2017 Jun;49(2):112-114.

11.

Role of AXL in invasion and drug resistance of colon and breast cancer cells and its association with p53 alterations.

Abdel-Rahman WM, Al-Khayyal NA, Nair VA, Aravind SR, Saber-Ayad M.

World J Gastroenterol. 2017 May 21;23(19):3440-3448. doi: 10.3748/wjg.v23.i19.3440.

12.

Consensus on Insulin Dose and Titration Algorithms in Ambulatory Care of Type 2 Diabetes in India.

Kovil R, Chawla M, Rajput R, Singh AK, Sinha B, Ghosal S, Ballani P, Gupta S, Tanna S, Bandukwala SM, Shah T, Negalur V, Bhoraskar A, Aravind SR, Zargar AH, Kesavadev J, Das AK.

J Assoc Physicians India. 2017 Feb;65(2):17-30.

PMID:
28457028
13.

Evidence-based recommendations for insulin intensification strategies after basal insulin in type 2 diabetes.

Ghosh S, Unnikrishnan AG, Saboo B, Kesavadev J, Aravind SR, Bajaj S, Rajput R, Seshadri K, Verma N, Gupta A, Makkar BM, Saikia M, Kale S, Damodaran S, Dengra A, Eashwar TKM, Maheshwari A, Pendsey S, Phatak SR, Sharma SK, Singh SK, Ramachandran A, Zargar AH, Joshi SR, Sadikot SM.

Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S507-S521. doi: 10.1016/j.dsx.2017.03.045. Epub 2017 Apr 5. Review.

PMID:
28433618
14.

Consensus recommendations on exploring effective solutions for the rising cost of diabetes.

Sadikot SM, Das AK, Wilding J, Siyan A, Zargar AH, Saboo B, Aravind SR, Sosale B, Kalra S, Vijayakumar G, Manojan KK, Maheshwari A, Panda JK, Banerjee S, Chawla R, Vasudevan SP, Sundar OSS, Kesavadev J.

Diabetes Metab Syndr. 2017 Apr - Jun;11(2):141-147. doi: 10.1016/j.dsx.2017.03.002. Epub 2017 Mar 7. Review.

PMID:
28325543
15.

Long-term Posterior Capsule Opacification Reduction with Square-Edge Polymethylmethacrylate Intraocular Lens: Randomized Controlled Study.

Haripriya A, Chang DF, Vijayakumar B, Niraj A, Shekhar M, Tanpreet S, Aravind S.

Ophthalmology. 2017 Mar;124(3):295-302. doi: 10.1016/j.ophtha.2016.11.010. Epub 2017 Jan 5.

PMID:
28065436
16.

Synthesis and biological evaluation of (-)-kunstleramide and its derivatives.

Venkateshwarlu R, Chinnababu B, Ramulu U, Purushotham Reddy K, Damoder Reddy M, Sowjanya P, Venkateswara Rao P, Aravind S.

Medchemcomm. 2016 Dec 9;8(2):394-404. doi: 10.1039/c6md00606j. eCollection 2017 Feb 1.

17.

Pseudopyronine B: A Potent Antimicrobial and Anticancer Molecule Isolated from a Pseudomonas mosselii.

Nishanth Kumar S, Aravind SR, Jacob J, Gopinath G, Lankalapalli RS, Sreelekha TT, Dileep Kumar BS.

Front Microbiol. 2016 Aug 26;7:1307. doi: 10.3389/fmicb.2016.01307. eCollection 2016. Retraction in: Front Microbiol. 2017 Nov 17;8:2263.

18.

Consensus Statement on Management of Post-Prandial Hyperglycemia in Clinical Practice in India.

Aravind S, Saboo B, Sadikot S, Shah SN, Makkar B, Kalra S, Kannampilly J, Kesavadev J, Ghoshal S, Zargar A, Nigam A, Hazra D, Tripathi K, Dharmalingam M, Shah P, Gandhi P, Sahay R, Unnikrishnan R, Gupta S, Bajaj S, Mukhopadhyay S, Kale S.

J Assoc Physicians India. 2015 Aug;63(8):45-58.

PMID:
27604435
19.

Curcumin-albumin conjugates as an effective anti-cancer agent with immunomodulatory properties.

Aravind SR, Krishnan LK.

Int Immunopharmacol. 2016 May;34:78-85. doi: 10.1016/j.intimp.2016.02.010. Epub 2016 Feb 27.

PMID:
26927614
20.

Protective effects of recombinant glycoprotein D based prime boost approach against duck enteritis virus in mice model.

Aravind S, Kamble NM, Gaikwad SS, Shukla SK, Saravanan R, Dey S, Mohan CM.

Microb Pathog. 2015 Nov;88:78-86. doi: 10.1016/j.micpath.2015.07.008. Epub 2015 Jul 15.

PMID:
26188265
21.

Circulating MiRNAs of 'Asian Indian Phenotype' Identified in Subjects with Impaired Glucose Tolerance and Patients with Type 2 Diabetes.

Prabu P, Rome S, Sathishkumar C, Aravind S, Mahalingam B, Shanthirani CS, Gastebois C, Villard A, Mohan V, Balasubramanyam M.

PLoS One. 2015 May 28;10(5):e0128372. doi: 10.1371/journal.pone.0128372. eCollection 2015.

22.

Galactoxyloglucan-modified nanocarriers of doxorubicin for improved tumor-targeted drug delivery with minimal toxicity.

Joseph MM, Aravind SR, George SK, Pillai KR, Mini S, Sreelekha TT.

J Biomed Nanotechnol. 2014 Nov;10(11):3253-68.

PMID:
26000385
23.

Anticancer activity of galactoxyloglucan polysaccharide-conjugated doxorubicin nanoparticles: Mechanistic insights and interactome analysis.

Joseph MM, Aravind SR, George SK, Raveendran Pillai K, Mini S, Sreelekha TT.

Eur J Pharm Biopharm. 2015 Jun;93:183-95. doi: 10.1016/j.ejpb.2015.04.001. Epub 2015 Apr 10.

PMID:
25864443
24.

Asarones from Acorus calamus in combination with azoles and amphotericin B: a novel synergistic combination to compete against human pathogenic Candida species in vitro.

Kumar SN, Aravind SR, Sreelekha TT, Jacob J, Kumar BS.

Appl Biochem Biotechnol. 2015 Apr;175(8):3683-95. doi: 10.1007/s12010-015-1537-y. Epub 2015 Feb 17.

PMID:
25686561
25.

TRAIL-based tumor sensitizing galactoxyloglucan, a novel entity for targeting apoptotic machinery.

Aravind SR, Joseph MM, George SK, Dileep KV, Varghese S, Rose-James A, Balaram P, Sadasivan C, Sreelekha TT.

Int J Biochem Cell Biol. 2015 Feb;59:153-66. doi: 10.1016/j.biocel.2014.11.019. Epub 2014 Dec 23.

PMID:
25541375
26.

Adaptation and growth kinetics study of an Indian isolate of virulent duck enteritis virus in Vero cells.

Aravind S, Kamble NM, Gaikwad SS, Shukla SK, Dey S, Mohan CM.

Microb Pathog. 2015 Jan;78:14-9. doi: 10.1016/j.micpath.2014.11.008. Epub 2014 Nov 13.

PMID:
25450886
27.

Co-encapsulation of Doxorubicin with galactoxyloglucan nanoparticles for intracellular tumor-targeted delivery in murine ascites and solid tumors.

Joseph MM, Aravind SR, George SK, Pillai RK, Mini S, Sreelekha TT.

Transl Oncol. 2014 Oct 24;7(5):525-36. doi: 10.1016/j.tranon.2014.07.003. eCollection 2014 Oct.

28.

Consensus guidelines for glycemic monitoring in type 1/type 2 & GDM.

Kesavadev J, Sadikot S, Wangnoo S, Kannampilly J, Saboo B, Aravind SR, Kalra S, Makkar BM, Maji D, Saikia M, Anjana RM, Rajput R, Singh SK, Shah S, Dhruv U, Vishwanathan V.

Diabetes Metab Syndr. 2014 Jul-Sep;8(3):187-95. doi: 10.1016/j.dsx.2014.04.030. Epub 2014 May 28.

PMID:
25200925
29.

Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort.

Yeung RO, Zhang Y, Luk A, Yang W, Sobrepena L, Yoon KH, Aravind SR, Sheu W, Nguyen TK, Ozaki R, Deerochanawong C, Tsang CC, Chan WB, Hong EG, Do TQ, Cheung Y, Brown N, Goh SY, Ma RC, Mukhopadhyay M, Ojha AK, Chakraborty S, Kong AP, Lau W, Jia W, Li W, Guo X, Bian R, Weng J, Ji L, Reyes-dela Rosa M, Toledo RM, Himathongkam T, Yoo SJ, Chow CC, Ho LL, Chuang LM, Tutino G, Tong PC, So WY, Wolthers T, Ko G, Lyubomirsky G, Chan JC.

Lancet Diabetes Endocrinol. 2014 Dec;2(12):935-43. doi: 10.1016/S2213-8587(14)70137-8. Epub 2014 Jul 28. Erratum in: Lancet Diabetes Endocrinol. 2014 Dec;2(12):e17.

PMID:
25081582
30.

Weight adds weight to declining quality of life in diabetes.

Aravind SR, Deshpande N.

Curr Med Res Opin. 2014 Jul;30(7):1275-8. doi: 10.1185/03007995.2014.901944. Epub 2014 Mar 26. No abstract available.

PMID:
24597862
31.

Adding a DPP-4 inhibitor to metformin therapy may be safer than you think.

Aravind SR.

Curr Med Res Opin. 2014 May;30(5):791-4. doi: 10.1185/03007995.2014.893867. Epub 2014 Feb 24. No abstract available.

PMID:
24517395
32.

Antitumor activity of galactoxyloglucan-gold nanoparticles against murine ascites and solid carcinoma.

Joseph MM, Aravind SR, George SK, Pillai KR, Mini S, Sreelekha TT.

Colloids Surf B Biointerfaces. 2014 Apr 1;116:219-27. doi: 10.1016/j.colsurfb.2013.12.058. Epub 2014 Jan 9.

PMID:
24486833
33.

Radiation-induced Extra-osseous Osteosarcoma-A Case Report and Review of Literature.

Vikram S, Salih S, Krishnan A, Nizamudheen MP, Babu S, Aravind S, Sangeetha N, Sateesan B.

Indian J Surg Oncol. 2013 Dec;4(4):374-7. doi: 10.1007/s13193-013-0262-7. Epub 2013 Aug 28. No abstract available.

34.

A galactomannan polysaccharide from Punica granatum imparts in vitro and in vivo anticancer activity.

Joseph MM, Aravind SR, George SK, Varghese S, Sreelekha TT.

Carbohydr Polym. 2013 Nov 6;98(2):1466-75. doi: 10.1016/j.carbpol.2013.07.023. Epub 2013 Jul 17.

PMID:
24053828
35.

Accelerated fat cell aging links oxidative stress and insulin resistance in adipocytes.

Monickaraj F, Aravind S, Nandhini P, Prabu P, Sathishkumar C, Mohan V, Balasubramanyam M.

J Biosci. 2013 Mar;38(1):113-22.

PMID:
23385819
36.

PST-Gold nanoparticle as an effective anticancer agent with immunomodulatory properties.

Joseph MM, Aravind SR, Varghese S, Mini S, Sreelekha TT.

Colloids Surf B Biointerfaces. 2013 Apr 1;104:32-9. doi: 10.1016/j.colsurfb.2012.11.046. Epub 2012 Dec 17.

PMID:
23298585
37.

Pharmacological characterization of LPS and opioid interactions at the toll-like receptor 4.

Stevens CW, Aravind S, Das S, Davis RL.

Br J Pharmacol. 2013 Mar;168(6):1421-9. doi: 10.1111/bph.12028.

38.
39.

Pt nanoparticle-dispersed graphene-wrapped MWNT composites as oxygen reduction reaction electrocatalyst in proton exchange membrane fuel cell.

Aravind SS, Ramaprabhu S.

ACS Appl Mater Interfaces. 2012 Aug;4(8):3805-10. doi: 10.1021/am301187h. Epub 2012 Aug 10.

PMID:
22850438
40.

Recombinant UL30 antigen-based single serum dilution ELISA for detection of duck viral enteritis.

Aravind S, Patil BR, Dey S, Mohan CM.

J Virol Methods. 2012 Nov;185(2):234-8. doi: 10.1016/j.jviromet.2012.06.027. Epub 2012 Jul 4.

PMID:
22771740
41.

Hypoglycemia in patients with type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic study.

Aravind SR, Ismail SB, Balamurugan R, Gupta JB, Wadhwa T, Loh SM, Suryawanshi S, Davies MJ, Girman CJ, Katzeff HL, Radican L, Engel SS, Wolthers T.

Curr Med Res Opin. 2012 Aug;28(8):1289-96. doi: 10.1185/03007995.2012.707119. Epub 2012 Jul 6.

PMID:
22738801
42.

Antitumor and immunopotentiating activity of polysaccharide PST001 isolated from the seed kernel of Tamarindus indica: an in vivo study in mice.

Aravind SR, Joseph MM, Varghese S, Balaram P, Sreelekha TT.

ScientificWorldJournal. 2012;2012:361382. doi: 10.1100/2012/361382. Epub 2012 Apr 19.

43.

Accelerated aging as evidenced by increased telomere shortening and mitochondrial DNA depletion in patients with type 2 diabetes.

Monickaraj F, Aravind S, Gokulakrishnan K, Sathishkumar C, Prabu P, Prabu D, Mohan V, Balasubramanyam M.

Mol Cell Biochem. 2012 Jun;365(1-2):343-50. doi: 10.1007/s11010-012-1276-0. Epub 2012 Mar 13.

PMID:
22411737
44.

Evaluation of antioxidant, antitumor and immunomodulatory properties of polysaccharide isolated from fruit rind of Punica granatum.

Joseph MM, Aravind SR, Varghese S, Mini S, Sreelekha TT.

Mol Med Rep. 2012 Feb;5(2):489-96. doi: 10.3892/mmr.2011.638. Epub 2011 Oct 18.

PMID:
22012001
45.

Marker-assisted breeding as next-generation strategy for genetic improvement of productivity and quality: can it be realized in cotton?

Boopathi NM, Thiyagu K, Urbi B, Santhoshkumar M, Gopikrishnan A, Aravind S, Swapnashri G, Ravikesavan R.

Int J Plant Genomics. 2011;2011:670104. doi: 10.1155/2011/670104. Epub 2011 Mar 20.

46.

Effect of preoperative counseling on fear from visual sensations during phacoemulsification under topical anesthesia.

Haripriya A, Tan CS, Venkatesh R, Aravind S, Dev A, Au Eong KG.

J Cataract Refract Surg. 2011 May;37(5):814-8. doi: 10.1016/j.jcrs.2010.11.041.

PMID:
21511150
47.

Hypoglycaemia in sulphonylurea-treated subjects with type 2 diabetes undergoing Ramadan fasting: a five-country observational study.

Aravind SR, Al Tayeb K, Ismail SB, Shehadeh N, Kaddaha G, Liu R, Balshaw R, Lesnikova N, Heisel O, Girman CJ, Musser BJ, Davies MJ, Katzeff HL, Engel SS, Radican L; 2009 Ramadan Study Group.

Curr Med Res Opin. 2011 Jun;27(6):1237-42. doi: 10.1185/03007995.2011.578245. Epub 2011 Apr 20.

PMID:
21506631
48.

Impaired miR-146a expression links subclinical inflammation and insulin resistance in Type 2 diabetes.

Balasubramanyam M, Aravind S, Gokulakrishnan K, Prabu P, Sathishkumar C, Ranjani H, Mohan V.

Mol Cell Biochem. 2011 May;351(1-2):197-205. doi: 10.1007/s11010-011-0727-3. Epub 2011 Jan 20.

PMID:
21249428
49.

Tetrahydroamentoflavone (THA) from Semecarpus anacardium as a potent inhibitor of xanthine oxidase.

Arimboor R, Rangan M, Aravind SG, Arumughan C.

J Ethnopharmacol. 2011 Feb 16;133(3):1117-20. doi: 10.1016/j.jep.2010.10.027. Epub 2010 Oct 20.

PMID:
20965242
50.

Anemia and thrombocytopenia in patients undergoing chemotherapy for solid tumors: a descriptive study of a large outpatient oncology practice database, 2000-2007.

Wu Y, Aravind S, Ranganathan G, Martin A, Nalysnyk L.

Clin Ther. 2009;31 Pt 2:2416-32. doi: 10.1016/j.clinthera.2009.11.020.

PMID:
20110050

Supplemental Content

Loading ...
Support Center